Filing Details

Accession Number:
0001477449-25-000083
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-06-03 17:37:10
Reporting Period:
2025-05-30
Filing Date:
2025-06-03
Accepted Time:
2025-06-03 17:37:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1477449 Teladoc Health Inc. TDOC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1375088 C Adam Vandervoort C/O Teladoc Health, Inc.,
155 E 44Th St, Floor 17
New York NY 10017
Chief Legal Officer, Secretary No Yes No No
Transaction Summary
Sold: 5,808 shares Avg. Price: $6.86 Total Value: $39,842.88
Number of Shares After Transactions: 69,773 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-05-30 1,505 $0.00 65,813 No 4 M Direct
Common Stock Acquisiton 2025-05-30 4,418 $0.00 70,231 No 4 M Direct
Common Stock Acquisiton 2025-05-30 5,350 $0.00 75,581 No 4 M Direct
Common Stock Disposition 2025-06-02 5,808 $6.86 69,773 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Performance Stock Units Disposition 2025-05-30 1,505 $0.00 1,505 $0.00
Common Stock Restricted Stock Units Disposition 2025-05-30 4,418 $0.00 4,418 $0.00
Common Stock Restricted Stock Units Disposition 2025-05-30 5,350 $0.00 5,350 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,520 No 4 M Direct
13,254 No 4 M Direct
37,450 No 4 M Direct
Footnotes
  1. Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  2. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  3. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
  4. The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  5. On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  6. One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.